An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Harris Williams Advises Agape Care Group on its Sale to Ridgemont Equity Partners
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Harris Williams has advised Agape Care Group on its sale to Ridgemont Equity Partners. Agape Care, a leader in hospice and palliative care in the Southeast, serves over 2,100 patients across South Carolina and Georgia, employing around 1,000 staff. The transaction reflects strong investor interest in the healthcare sector, driven by favorable trends such as an aging population and increased hospice utilization. Ridgemont has invested over $5.5 billion since 1993, focusing on equity investments up to $250 million, positioning Agape Care for continued growth.
Positive
Agape Care's leadership in hospice and palliative care enhances its appeal to investors.
Transaction indicates strong interest in healthcare investments due to aging population and increased hospice utilization.
Negative
None.
RICHMOND, Va.--(BUSINESS WIRE)--
Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Agape Care Group (Agape Care), a portfolio company of The Vistria Group (Vistria), on its sale to Ridgemont Equity Partners (Ridgemont). Agape Care is a leader in hospice and palliative care in the Southeast. The transaction was led by James Clark, Taylor Will and Jonathan Ferrell of the Harris Williams Healthcare & Life Sciences (HCLS) Group.
“The quality of hospice and palliative care services Agape Care provides, its extensive coverage and density in South Carolina and Georgia, and its investments in best-in-class centralized systems that drive quality and compliance have enabled it to become a provider of choice in its markets. Investors continue to be highly interested in the sector given favorable macro industry trends that include an aging population, increased hospice utilization, patients’ preference to age in place and the cost advantage of care in the home relative to alternative settings,” said James Clark, a managing director at Harris Williams. “It was a pleasure working with the teams at Agape Care and Vistria on this transaction and we look forward to watching the company continue to thrive in partnership with Ridgemont.”
As a leader in hospice and palliative care, Agape Care proudly serves over 2,100 patients across South Carolina and Georgia. The company has around 1,000 employees who are committed to serving with love those touched by an advanced illness, providing comfort and support through compassionate care and meaningful experiences. Agape Care offers hospice and palliative services across multiple settings and is renowned for its superior patient-family experience and expertly trained professionals.
Vistria is a Chicago-based private investment firm focused on investing in middle market companies in the healthcare, education and financial services sectors. Vistria's team is comprised of highly experienced operating partners and private equity executives with proven track records of working with management teams in building innovative, market-leading companies.
Ridgemont is a Charlotte, North Carolina-based middle market buyout and growth equity investor. Since 1993, the principals of Ridgemont have invested over $5.5 billion. The firm focuses on equity investments up to $250 million and utilizes a proven, industry-focused investment approach and repeatable value creation strategies. Ridgemont’s most recent flagship fund, REP III, was formed in 2018 and has $1.65 billion of committed capital.
Harris Williams, an investment bank specializing in M&A advisory services, advocates for sellers and buyers of companies worldwide through critical milestones and provides thoughtful advice during the lives of their businesses. By collaborating as one firm across Industry Groups and geographies, the firm helps its clients achieve outcomes that support their objectives and strategically create value. Harris Williams is committed to execution excellence and to building enduring, valued relationships that are based on mutual trust. Harris Williams is a subsidiary of the PNC Financial Services Group, Inc. (NYSE: PNC).
The Harris Williams HCLS Group has experience across a broad range of sectors, including healthcare providers; payors and payor services; outsourced pharmaceutical services; medical device supply chain; healthcare IT; and pharmacy. For more information on the HCLS Group and other recent transactions, visit the HCLS Group’s section of the Harris Williams website.
Harris Williams LLC is a registered broker-dealer and member of FINRA and SIPC. Harris Williams & Co. Ltd is a private limited company incorporated under English law with its registered office at 8th Floor, 20 Farringdon Street, London EC4A 4AB, UK, registered with the Registrar of Companies for England and Wales (registration number 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co.Corporate Finance Advisors GmbH is registered in the commercial register of the local court of Frankfurt am Main, Germany, under HRB 107540. The registered address is Bockenheimer Landstrasse 33-35, 60325 Frankfurt am Main, Germany (email address: hwgermany@harriswilliams.com). Geschäftsführer/Directors: Jeffery H. Perkins, Paul Poggi. (VAT No. DE321666994). Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co.Corporate Finance Advisors GmbH conduct business.
